The questions every GM, International Director or Business Development Manager, has been asking him- or herself almost every day. It is not easy to identify your best fitting international strategy for your specific product.
Although there is no only one strategy, we at Chameleon Pharma are sure that one of the most important changes the Consumer Health, Pharma, Cosmetic or Medical Device companies have to undertake is to ensure business success by entering new markets.
Most of the developed countries in Europe only show close to 1-2% growth or even negative growth.
On the other side, the “Emerging Markets” have experienced a remarkable growth of 12 to 14% per year and are supposed to grow further.
We at Chameleon Pharma Consulting support our clients by entering the new Emerging Markets and help to develop new business strategies best fitting to the needs of our clients. For more information about our CPC Strategic Approach please click here.
Featured image : Photo by Randy Fath on Unsplash
Feedback Form
Related Posts
The Challenges of Food Supplements and FSMPs Claims, Labelling and Classification in Europe
Get The Important Insights! The European nutrition, food supplements and foods for special medical Purposes (FSMPs) market has been experiencing...
The Growing Trend of Online OTC and Food Supplements Purchases in Italy
Get The Important Insights!The Italian e-commerce OTC and food supplements market is growing, driven by convenience and cost-saving for consumers....
The German OTC and Pharma Market: Outlook and Main Trends
Get The Important Insights!Germany is spearheading the European OTC and pharma market with consistent and active growth in the sector. Get important...